Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: BRAIN Biotech AG / Key word(s): PersonnelBRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes 29.05.2024 / 09:00 CET/CESTThe issuer is solely responsible for the content of this announcement.BRAIN Biotech AG announces the appointment of Erik de Vries a...
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company...
REDWOOD CITY, Calif., May 22, 2024 -- Codexis, Inc. , a leading enzyme engineering company, today announced the Company will attend the Jefferies Global Healthcare Conference, being held June 5-6,...
Codexis (NASDAQ:CDXS – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Benchmark in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $9.00 target price on the biotechnology company’s stock. Benchmark’s target price suggests a potential upside of 129.59% from the stock’s current […]
Q1 2024 Results May 2, 2024 We engineer enzymes Forward Looking Statements ...